Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

261.59
-1.7000-0.65%
Post-market: 262.981.39+0.53%19:57 EDT
Volume:4.39M
Turnover:1.15B
Market Cap:462.33B
PE:73.90
High:265.36
Open:264.60
Low:261.59
Close:263.29
52wk High:269.39
52wk Low:190.75
Shares:1.77B
Float Shares:1.76B
Volume Ratio:1.23
T/O Rate:0.25%
Dividend:6.83
Dividend Rate:2.61%
EPS(TTM):3.54
EPS(LYR):2.36
ROE:6225.00%
ROA:10.51%
PB:-77.90
PE(LYR):110.84

Loading ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 29

Citi Keeps Their Hold Rating on AbbVie (ABBV)

TIPRANKS
·
Sep 29

AbbVie price target raised to $289 from $282 at BofA

TIPRANKS
·
Sep 29

Analysts’ Top Healthcare Picks: AbbVie (ABBV), Quantum-Si (QSI)

TIPRANKS
·
Sep 29

US Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 28

FDA Approves AbbVie’s JUVMO for Adults with Parkinson’s Disease

Reuters
·
Sep 28

U.S. FDA Approves Abbvie's Juvmo™ (Tavapadon) for Parkinson's Disease

THOMSON REUTERS
·
Sep 28

Abbvie - Juvmo Expected to be Available in the U.S. in October 2026

THOMSON REUTERS
·
Sep 28

Analyst Reaffirms Buy Rating on AbbVie, Maintaining $280 Price Target After Strong CERVINO Phase III Data

TIPRANKS
·
Sep 28

US FDA Approves AbbVie's Drug for Parkinson's Disease

Reuters
·
Sep 26

US FDA - Approves Juvmo (Tavapadon) for Parkinson’s Disease in Adults on Sept 25, 2026

THOMSON REUTERS
·
Sep 26

ADARx Pharmaceuticals Shares Soar in NASDAQ Debut After Upsized IPO

Reuters
·
Sep 26

Oruka Therapeutics' Psoriasis Treatment Maintains 'Competitive Profile' After Positive Clinical Data, UBS Says

MT Newswires Live
·
Sep 25

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

Health Canada Approves AbbVie’s Epkinly Combo for Relapsed or Refractory Follicular Lymphoma in Adults

Reuters
·
Sep 24

Epkinly® Receives Health Canada Approval for Adults with Follicular Lymphoma

THOMSON REUTERS
·
Sep 24

RBC Capital Sticks to Its Buy Rating for AbbVie (ABBV)

TIPRANKS
·
Sep 24

Oruka Falls After Reporting Mid-Stage Data for Psoriasis Drug

Reuters
·
Sep 23

AbbVie Tells USTR Germany Drug Pricing Reforms Cut Innovative Medicine Value by Nearly 54%

Reuters
·
Sep 23

AbbVie: EC approves Rinvoq to treat polyarticular juvenile idiopathic arthritis

TIPRANKS
·
Sep 22